Health Care & Life Sciences » Pharmaceuticals | Daito Pharmaceutical Co. Ltd.

Daito Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is June-May. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
31,196
34,062
36,331
37,973
39,884
Cost of Goods Sold (COGS) incl. D&A
25,340
27,118
29,253
30,432
31,892
Gross Income
5,856
6,944
7,078
7,541
7,992
SG&A Expense
2,918
3,425
3,523
3,660
3,823
EBIT
2,945
3,519
3,556
3,881
4,169
Unusual Expense
56
2
280
92
20
Non Operating Income/Expense
58
99
189
60
98
Interest Expense
87
58
40
29
24
Pretax Income
2,869
3,373
3,426
3,885
4,263
Income Tax
1,065
1,136
879
1,258
1,251
Consolidated Net Income
1,805
2,236
2,547
2,627
3,012
Net Income
1,811
2,246
2,566
2,656
3,042
Net Income After Extraordinaries
1,811
2,246
2,566
2,656
3,042
Net Income Available to Common
1,811
2,246
2,566
2,656
3,042
EPS (Basic)
166.59
183.52
205.08
212.26
243.10
Basic Shares Outstanding
11
12
13
13
13
EPS (Diluted)
166.59
183.52
205.08
212.26
243.10
Diluted Shares Outstanding
11
12
13
13
13
EBITDA
5,390
5,959
6,199
6,699
7,022
Other Operating Expense
6
-
-
-
-
Non-Operating Interest Income
10
13
1
1
1
Minority Interest Expense
7
10
19
29
29

About Daito Pharmaceutical Co.

View Profile
Address
326 Yokamachi
Toyama Toyama 939
Japan
Employees -
Website http://www.daitonet.co.jp
Updated 07/08/2019
Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It offers drug substances, prescription and over-the-counter drugs, home-delivery medicine, and health food. The company was founded on June 30, 1942 and is headquartered in Toyama, Japan.